000 | 01857 a2200481 4500 | ||
---|---|---|---|
005 | 20250513044843.0 | ||
264 | 0 | _c19950223 | |
008 | 199502s 0 0 eng d | ||
022 | _a0741-5400 | ||
024 | 7 |
_a10.1002/jlb.57.1.135 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSoderberg, L S | |
245 | 0 | 0 |
_aInhalation exposure to isobutyl nitrite inhibits macrophage tumoricidal activity and modulates inducible nitric oxide. _h[electronic resource] |
260 |
_bJournal of leukocyte biology _cJan 1995 |
||
300 |
_a135-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
650 | 0 | 4 |
_aMacrophages, Peritoneal _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitrites _xadministration & dosage |
650 | 0 | 4 |
_aSarcoma, Kaposi _xetiology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
650 | 0 | 4 | _aomega-N-Methylarginine |
700 | 1 | _aBarnett, J B | |
773 | 0 |
_tJournal of leukocyte biology _gvol. 57 _gno. 1 _gp. 135-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jlb.57.1.135 _zAvailable from publisher's website |
999 |
_c7829310 _d7829310 |